What is Vivo?
Vivo operates as a specialized digital health platform, providing live, interactive, and small-group strength training programs specifically engineered for elderly individuals. By focusing on the intersection of geriatric wellness and remote fitness technology, the company addresses a critical gap in the healthcare market. Its model emphasizes accessibility and community-driven engagement, which are essential for improving health outcomes among older demographics. As the global population ages, Vivo is strategically positioned to capture significant market share by offering evidence-based physical training that promotes longevity and functional independence.
How much funding has Vivo raised?
Vivo has raised a total of $1.1M across 1 funding round:
Angel/Seed
$1.1M
Angel/Seed (2021): $1.1M, investors not publicly disclosed
Key Investors in Vivo
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Vivo?
With the recent infusion of capital, Vivo is expected to accelerate its product development cycle and expand its reach into new enterprise partnerships. The company's trajectory suggests a shift toward broader integration with healthcare providers and insurance networks, aiming to position its strength training programs as a standard component of preventative geriatric care. Future growth will likely hinge on the company's ability to maintain high engagement levels while scaling its live-interactive infrastructure to accommodate a larger user base. Investors are closely monitoring how this strategic financing will translate into long-term retention metrics and clinical validation of their fitness protocols.
See full Vivo company page